Deepnoid Inc. (315640)
KRX SM KRX SM Primary Summary
Deepnoid Inc. (315640) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Deepnoid Inc. ever had a stock split?
Deepnoid Inc. Profile
| Health Care Technology Industry | Healthcare Sector | Mr. Woosik Choi CEO | KRX SM Exchange | - ISIN |
| KR Country | - Employees | - Last Dividend | 6 Dec 2021 Last Split | - IPO Date |
Overview
Deep Noid Inc. is at the forefront of developing medical artificial intelligence (AI) solutions designed to enhance the accuracy and efficiency of healthcare services. Founded in 2008 and headquartered in Seoul, South Korea, the company specializes in leveraging AI to analyze clinical data—ranging from medical images to electronic medical records (EMR) of hospitals. Their AI solutions are adept at interpreting various forms of medical imagery such as CT scans, MRI, X-rays, and pathological slides, focusing on the detail-oriented study of disease-related cells and tissues. Deep Noid Inc.'s commitment to innovation in healthcare technology drives its mission to contribute to the early diagnosis and treatment of diseases, optimizing patient care processes globally.
Products and Services
Deep Noid Inc. offers an extensive portfolio of AI-driven medical solutions, each tailored to meet the needs of specific medical fields and applications. Among their notable offerings are:
- DEEP:NEURO - Targets neurological diseases, utilizing AI to analyze brain imaging data for the early detection and monitoring of neurological conditions.
- DEEP:LUNG - Focuses on lung diseases, applying AI algorithms to interpret chest radiographs and CT scans for the diagnosis and management of pulmonary disorders.
- DEEP:SPINE - This solution aids in the diagnosis and treatment planning of spinal conditions through the precise analysis of spine imaging studies.
- DEEP:CHEST - Designed to support the evaluation of thoracic diseases, combining AI technology to assess chest X-rays for abnormalities and diseases.
- DEEP:BREAST - Specializes in the detection and analysis of breast cancer, enhancing mammography screening processes with AI accuracy.
- DEEP:ENDO - Utilizes AI to improve the quality and outcomes of endoscopic procedures, focusing on the detection of gastrointestinal diseases.
- DEEP:DENTAL - Applies AI in dentistry, analyzing dental images for the early detection of oral diseases and conditions.
- DEEP:FUNDUS - A solution aimed at ophthalmology, employing AI in the analysis of fundus photographs for the identification of eye diseases.
- DEEP:PATH - Advances the field of pathology with AI, optimizing the examination of pathological slides for accurate disease diagnosis.
- DEEP:LIVER - Dedicated to the study of liver diseases, this tool leverages AI for the analysis of liver imaging data, aiding in the early diagnosis and treatment planning.
